You are here

  • Home
  • Archive
  • Volume 93, Issue 1098
  • A study in high-risk, maximally pretreated patients to determine the potential use of PCSK9 inhibitors at various thresholds of total and LDL cholesterol levels

Article metrics

Article menu
Download PDFPDF
Original article
A study in high-risk, maximally pretreated patients to determine the potential use of PCSK9 inhibitors at various thresholds of total and LDL cholesterol levels

 

Online download statistics by month:

Online download statistics by month: August 2016 to February 2023

AbstractFullPdf
Aug 20162381426
Sep 2016137108
Oct 20165852
Nov 20166378
Dec 20163731
Jan 20172741
Feb 201742104
Mar 20171742810
Apr 20172111013
May 20175364
Jun 20177165
Jul 20178511
Aug 20176823
Sep 20175912
Oct 20175844
Nov 201710500
Dec 20177233
Jan 201810922
Feb 20187675
Mar 20185811
Apr 20187421
May 20187410
Jun 20187111
Jul 201811800
Aug 20189011
Sep 20188822
Oct 20186840
Nov 20187220
Dec 20185620
Jan 20194000
Feb 20196011
Mar 201949124
Apr 20194411
May 20193061
Jun 20192100
Jul 20193910
Aug 20192600
Sep 20193500
Oct 20193000
Nov 20194500
Dec 20193720
Jan 20205122
Feb 20202620
Mar 20201800
Apr 20201311
May 202012310
Jun 202017721
Jul 202011131
Aug 20202100
Sep 20204712
Oct 20205611
Nov 20203000
Dec 20202400
Jan 20212611
Feb 20213901
Mar 20211400
Apr 20212710
May 20211201
Jun 2021332
Aug 2021100
Sep 2021111
Oct 20212861
Nov 20212600
Dec 20213210
Jan 20223244
Feb 20223822
Mar 20224710
Apr 20223500
May 20227910
Jun 20227320
Jul 20223600
Aug 20227320
Sep 20226110
Oct 20224012
Nov 20222011
Dec 20221500
Jan 20232201
Feb 2023800
Total4453203140